NEWS

01/04/2020

Evidence COVID-19

Researchers from the Research Group on Clinical Epidemiology and Health Services of the Sant Pau Research Institute – IIB Sant Pau, in collaboration with the Iberoamerican Cochrane Network, have launched “Evidences COVID-19”, a new information resource that offers relevant related information with the SARS-CoV-2 and COVID-19 coronavirus pandemic.

This resource, which is continuously updated and expanded, offers a series of documents that synthesize the most relevant information to answer priority questions about the pandemic, in the form of reviews of the scientific literature and critical evaluations of published studies.

The documents are intended to synthesize and update the knowledge available regarding COVID-19, and give a collaborative response to the current health emergency. These documents address issues related to the epidemiology, clinical, prevention, and treatment of SARS-CoV-2 and COVID-19 infection.

The documents that are being published in this resource are of different types:

• COVID19 responses: quick reviews of the literature that answer priority questions, locally or globally, from other existing knowledge transfer products or, when necessary, from primary studies.
• Study COVID-19: Comment on the structures that are filled in by the new or original information on the coronavirus and COVID-19.
• COVID-19 clinical trials: structured comments from published clinical trials of treatments in patients with COVID-19 or strategies for disease prevention.
• Cochrane Reviews: Links to Cochrane systematic reviews included in the first two special collections that Cochrane has prepared as content related to the COVID-19 pandemic, for infection control and prevention and critical care.

This resource can be consulted in Catalan on the website of the Research Institute: https://www.recercasantpau.cat/noticies-grup/evidencies-covid-19/ and in Spanish on the website of the Center Cochrane Iberoamericà: https: //es.cochrane.org/es/recursos/evidencias-covid-19